Pricing Log in Create free account

Panbela Therapeutics Inc. (PBLA) vs Propanc Biopharma Inc (PPCB)

Panbela Therapeutics Inc. and Propanc Biopharma Inc are both Biotechnology companies. Panbela Therapeutics Inc. and Propanc Biopharma Inc are of similar size ($3.5M and $3.4M). Across the 9 metrics below, Panbela Therapeutics Inc. leads on 7 and Propanc Biopharma Inc on 2.

Valuation

Metric PBLA PPCB Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m 0.04 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield 0.00% (5,398.12%) (33.15%)
Free cash flow yield 0.00% (1,488.65%) (25.50%)

Profitability

Metric PBLA PPCB Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 270.37% (169.85%) (56.36%)
Return on assets (353.47%) (122.15%) (48.04%)
Return on invested capital 0.00% (125.86%) 0.00%

Growth

Metric PBLA PPCB Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 99.43% 95.25% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PBLA PPCB Biotechnology median
Debt to equity (0.23) 0.05 0.00
Current ratio 0.26 2.55 4.72
Net debt to EBITDA (0.10) 0.02 0.96

Dividend

Metric PBLA PPCB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PBLA PPCB Biotechnology median
Market cap 3.35m 3.53m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack